SAVE 📈 Savencia SA - Overview
Exchange: PA • Country: France • Currency: EUR • Type: Common Stock • ISIN: FR0000120107
SAVE: Cheese, Butters, Creams, Dairy Ingredients, Nutritional Solutions
Savencia SA produces, distributes, and markets dairy and cheese products in France, rest of Europe, and internationally. It offers cheese, butters, creams, and dairy ingredients and nutritional solutions for the retail market and foodservices market. The company provides its products under the Caprice des Dieux, Saint Albray, Le Rustique, C'ur de Lion, Saint Agur, Bresse Bleu, PDO Roquefort Papillon, St-Morêt, Tartare, Carré Frais, Apérivrais, Chavroux, Saint-Loup, RichesMonts raclette, Géramont, Saint Albray, Fol Epi, Bresso, Milkana, Brunch, Burgo de Arias, Ile de France, Milkaut, Santa Rosa, Delaco, Kral Syru, Lucina, Král Sýru, Medve, Alouette, Rogue Creamery, Polenghi, Corman, Balade, and Elle & Vire brands. The company was formerly known as Bongrain SA and changed its name to Savencia SA in April 2015.Savencia SA was founded in 1956 and is headquartered in Viroflay, France. Savencia SA operates as a subsidiary of Savencia Holding. Web URL: https://savencia-fromagedairy.com
Additional Sources for SAVE Stock
SAVE Stock Overview
| Market Cap in USD | 749m |
| Sector | Consumer Defensive |
| Industry | Packaged Foods |
| GiC Sub-Industry | Packaged Foods & Meats |
| IPO / Inception |
SAVE Stock Ratings
| Growth 5y | -8.43% |
| Fundamental | 69.0% |
| Dividend | 34.6% |
| Rel. Strength Industry | -94.3 |
| Analysts | - |
| Fair Price Momentum | 49.20 EUR |
| Fair Price DCF | 230.03 EUR |
SAVE Dividends
| Dividend Yield 12m | 2.70% |
| Yield on Cost 5y | 2.56% |
| Annual Growth 5y | 5.39% |
| Payout Consistency | 86.1% |
SAVE Growth Ratios
| Growth Correlation 3m | 20.9% |
| Growth Correlation 12m | -4.4% |
| Growth Correlation 5y | -12.4% |
| CAGR 5y | -0.94% |
| CAGR/Mean DD 5y | -0.05 |
| Sharpe Ratio 12m | -0.27 |
| Alpha | -12.59 |
| Beta | 0.26 |
| Volatility | 22.34% |
| Current Volume | 1.7k |
| Average Volume 20d | 1.8k |
What is the price of SAVE stocks?
As of December 21, 2024, the stock is trading at EUR 52.20 with a total of 1,687 shares traded.
Over the past week, the price has changed by -5.47%, over one month by +2.78%, over three months by +2.37% and over the past year by +0.77%.
As of December 21, 2024, the stock is trading at EUR 52.20 with a total of 1,687 shares traded.
Over the past week, the price has changed by -5.47%, over one month by +2.78%, over three months by +2.37% and over the past year by +0.77%.
Is Savencia SA a good stock to buy?
Yes, based on ValueRay Fundamental Analyses, Savencia SA (PA:SAVE) is currently (December 2024) a good stock to buy. It has a ValueRay Fundamental Rating of 69.04 and therefor a positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of SAVE as of December 2024 is 49.20. This means that SAVE is currently overvalued and has a potential downside of -5.75%.
Yes, based on ValueRay Fundamental Analyses, Savencia SA (PA:SAVE) is currently (December 2024) a good stock to buy. It has a ValueRay Fundamental Rating of 69.04 and therefor a positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of SAVE as of December 2024 is 49.20. This means that SAVE is currently overvalued and has a potential downside of -5.75%.
Is SAVE a buy, sell or hold?
Savencia SA has no consensus analysts rating.
Savencia SA has no consensus analysts rating.
What are the forecast for SAVE stock price target?
According to ValueRays Forecast Model, SAVE Savencia SA will be worth about 53.1 in December 2025. The stock is currently trading at 52.20. This means that the stock has a potential upside of +1.8%.
According to ValueRays Forecast Model, SAVE Savencia SA will be worth about 53.1 in December 2025. The stock is currently trading at 52.20. This means that the stock has a potential upside of +1.8%.
| Issuer | Forecast | Upside |
|---|---|---|
| Wallstreet Target Price | 58.1 | 11.2% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 53.1 | 1.8% |